Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Omnicell (OMCL)
NASDAQ:OMCL
Omnicell (OMCL) Stock Price & Analysis
248 Followers
OMCL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.69 - $77.14
Previous Close$32.63
Volume475.31K
Average Volume (3M)483.80K
Market Cap
$1.50B
Enterprise Value$1.65B
Total Cash (Recent Filing)$446.80M
Total Debt (Recent Filing)$601.69M
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Jul 30, 2024EPS Estimate
$0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding45,923,492
10 Day Avg. Volume447,733
30 Day Avg. Volume483,803
Standard Deviation0.12
R-Squared0.13
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)6.19
Price to Sales (P/S)5.03
Price to Cash Flow (P/CF)9.80
P/FCF Ratio9.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.53
Enterprise Value/Gross Profit2.81
Enterprise Value/Ebitda57.61
Forecast
1Y Price Target
$33.14Price Target Upside1.56% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Omnicell News
PremiumPre-Earnings
Omnicell (OMCL) Q1 Earnings Cheat Sheet
PremiumCompany Announcements
Omnicell Announces Executive Retirement and New VP Appointment
Bulls Say, Bears Say
Bulls Say
Financial OutlookWith new customer wins and a potential upturn in the hospital spending environment, Omnicell's financial outlook appears promising as the company continues to deliver high-quality products that promote medication adherence and improved patient outcomes.
Innovation And ResponsivenessOmnicell demonstrates a strong commitment to innovation and customer satisfaction, as evidenced by the AnywhereRN solution, which was enhanced through key feedback from Inspira Health.
Product DemandOmnicell's Automatic Cabinet Dispensaries (ADCs) are setting the standard in the industry with their superior capacity, cutting-edge software, and extended lifespan, making them a top choice over competitors.
Bears Say
Financial PerformanceA 15% year-over-year decline in revenue, and a 60% year-over-year decline in adjusted EBITDA both indicate that the business is going through a major transition.
Investment AppealInspira Health has not found the Return on Investment (ROI) for Omnicell's robotics compelling enough to justify the purchase.
Labor Market DataThere is potential overlap in job listings which could mean the data on technician job openings may be overstated by up to 18%.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
OMCL FAQ
What was Omnicell’s price range in the past 12 months?
Omnicell lowest stock price was $25.69 and its highest was $77.14 in the past 12 months.
What is Omnicell’s market cap?
Currently, no data Available
When is Omnicell’s upcoming earnings report date?
Omnicell’s upcoming earnings report date is Jul 30, 2024 which is in 63 days.
How were Omnicell’s earnings last quarter?
Omnicell released its earnings results on May 02, 2024. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of -$0.093 by $0.123.
Is Omnicell overvalued?
According to Wall Street analysts Omnicell’s price is currently Undervalued.
Does Omnicell pay dividends?
Omnicell does not currently pay dividends.
What is Omnicell’s EPS estimate?
Omnicell’s EPS estimate is $0.14.
How many shares outstanding does Omnicell have?
Omnicell has 45,923,492 shares outstanding.
What happened to Omnicell’s price movement after its last earnings report?
Omnicell reported an EPS of $0.03 in its last earnings report, beating expectations of -$0.093. Following the earnings report the stock price went up 7.803%.
Which hedge fund is a major shareholder of Omnicell?
Among the largest hedge funds holding Omnicell’s share is Fisher Asset Management LLC. It holds Omnicell’s shares valued at 7M.
---
Omnicell Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$33.14 (1.56% Upside)
$33.14 (1.56% Upside)
Blogger Sentiment
Bullish
OMCL Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 13.8K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.33%
12-Months-Change
Fundamentals
Return on Equity
-1.81%
Trailing 12-Months
Asset Growth
1.46%
Trailing 12-Months
Company Description
Omnicell
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.
---
OMCL Company Deck
---
OMCL Earnings Call
Q1 2024
0:00 / 0:00
---
OMCL Stock 12 Month Forecast
Average Price Target
$33.14
▲(1.56% Upside)
Technical Analysis
Best Analysts Covering OMCL
1 Year
1 Year Success Rate
8/15 ratings generated profit
1 Year Average Return
+3.27%
reiterated a buy rating 25 days ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 53.33% of your transactions generating a profit, with an average return of +3.27% per trade.
---